<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>4-hydroxybenzoic acid is_biomarker_for colorectal cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>4-hydroxybenzoic acid</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>colorectal cancer</strong>
</div>
<div class="entity-id">HMDB:HMDB0000500 &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: Curated (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 6.09<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (Curated, 1 paper)<br>Score from 11 citations: <strong>6.09</strong><br><span style="color:#888">3&times; extends (+1.80) &middot; 8&times; supports (+4.29)</span></div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.1155/2022/1758113">10.1155/2022/1758113</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 11 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>8</span><span class="cite-subtotal">&middot; +4.29</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">citrate — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.79</span><a href="../claim/5a27794ca006f48f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">dci-MSEA — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/9f7d9707b4841fdd.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">dci-MSEA — predicts → altered metabolic pathways in colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/e4a2d4204edc59be.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Glyoxylate and dicarboxylate metabolism pathway — distinguishes → average-onset colorectal cancer vs early-onset colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/87f58bba8b521769.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Alanine, aspartate, and glutamate metabolism pathway — distinguishes → average-onset colorectal cancer vs early-onset colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/1e649391cdadbf03.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Glycine, serine, and threonine metabolism pathway — distinguishes → average-onset colorectal cancer vs early-onset colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/9a333834b0032363.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Amino-acid tRNA biosynthesis pathway — distinguishes → average-onset colorectal cancer vs early-onset colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/f9a01136bc63f5bd.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">4-Hydroxyhippuric acid — predicts → overall survival in colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/06987bb27976d62e.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:38px"></span><span>3</span><span class="cite-subtotal">&middot; +1.80</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">differential correlations between metabolites — is_biomarker_for → colorectal cancer heterogeneity</span><span class="cite-claim-weight">+0.60</span><a href="../claim/69843cad861fb5c7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Arginine biosynthesis pathway — distinguishes → average-onset colorectal cancer vs early-onset colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/a7b545abea48af0b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Citrate cycle (TCA cycle) pathway — distinguishes → average-onset colorectal cancer vs early-onset colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/56bcca597d5ee036.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>6392e7363ddfadd7</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/HMDB:HMDB0000500">HMDB:HMDB0000500</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
